The Vitamin D Receptor Ortholog Hr96 Modulates Neuronal and Mitochondrial Dynamics in a Drosophila Model of Alzheimer's Disease. 2025

Guilherme Gischkow Rucatti, and Francisco Muñoz-Carvajal, and Nicole Sanhueza, and Sebastian Oyarce-Pezoa, and Yesid Cuesta-Astroz, and Leandro Murgas, and Melissa Caru-Ruiz, and Alberto J M Martin, and Melissa Calegaro-Nassif, and Carol D SanMartín, and Mario Sanhueza
Center for Resilience, Adaptation and Mitigation, Universidad Mayor, Temuco, Chile.

Alzheimer's disease (AD) is the most common cause of dementia, characterized by amyloid-β (Aβ42) accumulation, with a progressive breakdown of synapsis connection, neuronal death, and cognitive loss. Mitochondrial impairment emerges early in AD, preceding cognitive symptoms and contributing to disease progression. Vitamin D (VD) is a neurosteroid that acts as a transcription factor through its nuclear receptor, the vitamin D receptor (VDR), playing a central role in metabolic control. The Drosophila VDR ortholog, hormone receptor 96 (Hr96), is known to regulate xenobiotic protection and energy metabolism, but its neuronal functions and impact on AD pathomechanisms are poorly understood. Here, we investigate Hr96's role in neuronal and mitochondrial homeostasis, hypothesizing that its signaling modulates mitochondrial dynamics and mitigates neurodegeneration in AD. We identified Hr96-regulated genes involved in lipid metabolism, oxidative stress, and mitochondrial dynamics. Modulation of Hr96 expression in fly neurons revealed that knockdown had minimal early effects but led to reduced lifespan and motor decline, while overexpression induced metabolic imbalances, circadian disruptions, and premature mortality. Mitochondrial analyses showed that Hr96 overexpression affected functionality, increased fragmentation, and upregulated fission markers, such as Drp1, suggesting a role in mitochondrial dynamics. Then, when we studied an AD fly model, Hr96 loss exacerbated Aβ42-induced neurotoxicity, reducing lifespan and motor performance. Conversely, Hr96 overexpression extended lifespan under Aβ42 toxicity but did not affect neuromuscular junction bouton number and size. Furthermore, when mitochondrial parameters were analyzed, overexpression of this gene suppresses Aβ42-linked mitochondrial phenotypes to levels closer to wild type. These findings unveil Hr96 as a potential modulator of mitochondrial and neuronal homeostasis, and that in the context of a time-dependent insult such as Aβ42 accumulation, its overexpression is protective. Further studies are needed to elucidate its role in mitochondrial regulation and transcriptional networks, paving the way for therapeutic strategies targeting mitochondrial dysfunction in neurodegeneration.

UI MeSH Term Description Entries

Related Publications

Guilherme Gischkow Rucatti, and Francisco Muñoz-Carvajal, and Nicole Sanhueza, and Sebastian Oyarce-Pezoa, and Yesid Cuesta-Astroz, and Leandro Murgas, and Melissa Caru-Ruiz, and Alberto J M Martin, and Melissa Calegaro-Nassif, and Carol D SanMartín, and Mario Sanhueza
December 2009, PloS one,
Guilherme Gischkow Rucatti, and Francisco Muñoz-Carvajal, and Nicole Sanhueza, and Sebastian Oyarce-Pezoa, and Yesid Cuesta-Astroz, and Leandro Murgas, and Melissa Caru-Ruiz, and Alberto J M Martin, and Melissa Calegaro-Nassif, and Carol D SanMartín, and Mario Sanhueza
September 2010, International journal of Alzheimer's disease,
Guilherme Gischkow Rucatti, and Francisco Muñoz-Carvajal, and Nicole Sanhueza, and Sebastian Oyarce-Pezoa, and Yesid Cuesta-Astroz, and Leandro Murgas, and Melissa Caru-Ruiz, and Alberto J M Martin, and Melissa Calegaro-Nassif, and Carol D SanMartín, and Mario Sanhueza
January 2021, Molecular neurobiology,
Guilherme Gischkow Rucatti, and Francisco Muñoz-Carvajal, and Nicole Sanhueza, and Sebastian Oyarce-Pezoa, and Yesid Cuesta-Astroz, and Leandro Murgas, and Melissa Caru-Ruiz, and Alberto J M Martin, and Melissa Calegaro-Nassif, and Carol D SanMartín, and Mario Sanhueza
September 2015, Experimental gerontology,
Guilherme Gischkow Rucatti, and Francisco Muñoz-Carvajal, and Nicole Sanhueza, and Sebastian Oyarce-Pezoa, and Yesid Cuesta-Astroz, and Leandro Murgas, and Melissa Caru-Ruiz, and Alberto J M Martin, and Melissa Calegaro-Nassif, and Carol D SanMartín, and Mario Sanhueza
August 2012, Neurobiology of aging,
Guilherme Gischkow Rucatti, and Francisco Muñoz-Carvajal, and Nicole Sanhueza, and Sebastian Oyarce-Pezoa, and Yesid Cuesta-Astroz, and Leandro Murgas, and Melissa Caru-Ruiz, and Alberto J M Martin, and Melissa Calegaro-Nassif, and Carol D SanMartín, and Mario Sanhueza
May 2024, Cell death & disease,
Guilherme Gischkow Rucatti, and Francisco Muñoz-Carvajal, and Nicole Sanhueza, and Sebastian Oyarce-Pezoa, and Yesid Cuesta-Astroz, and Leandro Murgas, and Melissa Caru-Ruiz, and Alberto J M Martin, and Melissa Calegaro-Nassif, and Carol D SanMartín, and Mario Sanhueza
August 2017, Neurobiology of aging,
Guilherme Gischkow Rucatti, and Francisco Muñoz-Carvajal, and Nicole Sanhueza, and Sebastian Oyarce-Pezoa, and Yesid Cuesta-Astroz, and Leandro Murgas, and Melissa Caru-Ruiz, and Alberto J M Martin, and Melissa Calegaro-Nassif, and Carol D SanMartín, and Mario Sanhueza
October 2011, Neuroscience letters,
Guilherme Gischkow Rucatti, and Francisco Muñoz-Carvajal, and Nicole Sanhueza, and Sebastian Oyarce-Pezoa, and Yesid Cuesta-Astroz, and Leandro Murgas, and Melissa Caru-Ruiz, and Alberto J M Martin, and Melissa Calegaro-Nassif, and Carol D SanMartín, and Mario Sanhueza
July 2007, The Tohoku journal of experimental medicine,
Guilherme Gischkow Rucatti, and Francisco Muñoz-Carvajal, and Nicole Sanhueza, and Sebastian Oyarce-Pezoa, and Yesid Cuesta-Astroz, and Leandro Murgas, and Melissa Caru-Ruiz, and Alberto J M Martin, and Melissa Calegaro-Nassif, and Carol D SanMartín, and Mario Sanhueza
January 2023, Journal of Alzheimer's disease : JAD,
Copied contents to your clipboard!